default author photo

Xin Jin

Huazhong University of Science and Technology - Cancer Biology Research Center

Wuhan

China

SCHOLARLY PAPERS

1

DOWNLOADS

55

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

The Liv-1-Grpel1 Axis Dictates Cell Fate During Anti-Mitotic Agent-Damaged Mitosis

, EBioMedicine, Volume 49, November 2019, Pages 26-39, https://doi.org/10.1016/j.ebiom.2019.09.054
Number of pages: 60 Posted: 22 Jul 2019
Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Department of Hematology, Huazhong University of Science and Technology - Tongji Medical College, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Department of Gastrointestinal Surgery, Huazhong University of Science and Technology (Formerly Tongi Medical University) - National Clinical Research Center for Gynecology and Obstetrics, Huazhong University of Science and Technology - Cancer Biology Research Center, Huazhong University of Science and Technology - Cancer Biology Research Center and Huazhong University of Science and Technology - Department of Obstetrics and Gynecology
Downloads 55 (1,020,567)

Abstract:

Loading...

LIV-1-GRPEL1 axis; mitotic exit; Apoptosis; anti-mitotic agents; human cancer